$DYNT
DYNATRONICS CORP Stock $dynt

$dynt Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-K Financial Statement

#000106299324016944 Filed on September 24, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2024
Revenue	$7.602M		$32.53M
YoY Change	-18.71%		-19.89%
Cost Of Revenue	$5.621M		$24.90M
YoY Change	-20.22%		-18.25%
Gross Profit	$1.981M		$7.635M
YoY Change	-14.1%		-24.78%
Gross Profit Margin	26.06%		23.47%
Selling, General & Admin	$2.232M		$9.908M
YoY Change	-12.33%		-33.95%
% of Gross Profit	112.67%		129.77%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization			$680.8K
YoY Change			61.51%
% of Gross Profit			8.92%
Operating Expenses	$2.232M		$9.908M
YoY Change	-12.33%		-33.95%
Operating Profit	-$251.0K		-$2.273M
YoY Change	4.8%		-53.15%
Interest Expense	$106.3K		$418.0K
YoY Change	33.46%		253.32%
% of Operating Profit
Other Income/Expense, Net	-$106.3K		-$424.7K
YoY Change	33.46%		248.93%
Pretax Income	-$357.3K		-$2.698M
YoY Change	11.96%		-45.76%
Income Tax	$9.304K		$0.00
% Of Pretax Income
Net Earnings	-$366.6K	-$687.9K	-$2.698M
YoY Change	10.89%	-71.11%	-45.76%
Net Earnings / Revenue	-4.82%		-8.29%
Basic Earnings Per Share	-$0.09		-$1.00
Diluted Earnings Per Share	-$0.09		-$1.00
COMMON SHARES
Basic Shares Outstanding	5.896M shares	5.309M shares	3.422M shares
Diluted Shares Outstanding	5.890M shares		3.422M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$278.4K	$483.9K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$5.471M	$5.594M
Prepaid Expenses	$461.9K	$530.4K
Receivables	$3.056M	$3.445M
Other Receivables	$513.2K	$454.4K
Total Short-Term Assets	$9.831M	$10.56M
YoY Change	-25.66%	-14.99%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.812M	$1.969M
YoY Change	-21.8%	-19.56%
Goodwill	$7.117M	$7.117M
YoY Change	0.0%	0.0%
Intangibles	$2.845M	$3.000M
YoY Change	-17.85%	-17.09%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$15.23M	$15.38M
YoY Change	-11.03%	-12.81%
TOTAL ASSETS
Total Short-Term Assets	$9.831M	$10.56M
Total Long-Term Assets	$15.23M	$15.38M
Total Assets	$25.06M	$25.94M
YoY Change	-17.41%	-13.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.739M	$2.712M
YoY Change	-29.28%	-40.13%
Accrued Expenses	$516.7K	$725.7K
YoY Change	-51.59%	-18.59%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.296M	$7.705M
YoY Change	-18.05%	-2.97%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities	$185.8K	$189.9K
YoY Change	-7.13%	-5.88%
Total Long-Term Liabilities	$185.8K	$189.9K
YoY Change	-7.13%	-5.88%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.296M	$7.705M
Total Long-Term Liabilities	$185.8K	$189.9K
Total Liabilities	$11.27M	$11.78M
YoY Change	-18.35%	-10.8%
SHAREHOLDERS EQUITY
Retained Earnings	-$29.44M	-$28.91M
YoY Change	13.21%	13.46%
Common Stock	$35.26M	$35.09M
YoY Change	1.98%	2.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.79M	$14.16M
YoY Change
Total Liabilities & Shareholders Equity	$25.06M	$25.94M
YoY Change	-17.41%	-13.71%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2024
OPERATING ACTIVITIES
Net Income	-$366.6K	-$687.9K	-$2.698M
YoY Change	10.89%	-71.11%	-45.76%
Depreciation, Depletion And Amortization			$680.8K
YoY Change			61.51%
Cash From Operating Activities	$100.6K		-$1.610M
YoY Change	-106.04%		-533.94%
INVESTING ACTIVITIES
Capital Expenditures	$0.00		$243.3K
YoY Change	-100.0%		30.2%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00		-$243.3K
YoY Change	-100.0%		30.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net			$0.00
YoY Change			-100.0%
Cash From Financing Activities	-$306.1K		$1.835M
YoY Change	-117.66%		-651.58%
NET CHANGE
Cash From Operating Activities	$100.6K		-$1.610M
Cash From Investing Activities	$0.00		-$243.3K
Cash From Financing Activities	-$306.1K		$1.835M
Net Change In Cash	-$205.5K		-$18.54K
YoY Change	-706.26%		-87.51%
FREE CASH FLOW
Cash From Operating Activities	$100.6K		-$1.610M
Capital Expenditures	$0.00		$243.3K
Free Cash Flow	$100.6K		-$1.854M
YoY Change	-105.92%		-1106.02%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	0-12697
CY2024	dei	Entity Registrant Name EntityRegistrantName	Dynatronics Corporation
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	UT
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0398434
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	1200 Trapp Road
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Eagan
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55121
CY2024	dei	City Area Code CityAreaCode	801
CY2024	dei	Local Phone Number LocalPhoneNumber	568-7000
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Public Float EntityPublicFloat	1800000	usd
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5896264	shares
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	483918	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	398797	usd
CY2024Q2	us-gaap	Restricted Cash RestrictedCash	50410	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	48997	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	154073	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	131403	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3444587	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3721677	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	701456	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	10557635	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3631780	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3618275	usd
CY2023Q2	us-gaap	Goodwill Goodwill	7116614	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2999975	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	829049	usd
CY2024Q2	us-gaap	Other Assets OtherAssets	465505	usd
CY2023Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	115637	usd
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q2	dynt	Current Portion Of Deferred Gain CurrentPortionOfDeferredGain	150448	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1075690	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	13744	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	0	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7704910	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7940992	usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1731868	usd
CY2024Q2	dynt	Deferred Gain Net Of Noncurrent Portion DeferredGainNetOfNoncurrentPortion	626866	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2554450	usd
CY2024Q2	us-gaap	Liabilities Liabilities	11780115	usd
CY2024Q2	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2023Q2	us-gaap	Liabilities Liabilities	13206349	usd
CY2023Q2	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3351000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3351000	shares
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	7980788	usd
CY2023Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5308519	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4044984	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5308519	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4044984	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	35087825	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	34355315	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25479577	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	14160444	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	16856526	usd
CY2024	us-gaap	Revenues Revenues	32533965	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30062875	usd
CY2024	us-gaap	Gross Profit GrossProfit	7634978	usd
CY2023	us-gaap	Gross Profit GrossProfit	10150102	usd
CY2023	us-gaap	Revenues Revenues	40609372	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	24898987	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	30459270	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15001765	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-2273048	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-4851663	usd
CY2024	us-gaap	Interest Expense InterestExpense	418005	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3398	usd
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3870670	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4973368	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3870670	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.46
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	131336	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	21698558	usd
CY2023	dynt	Adjustment For Fractional Shares Value AdjustmentForFractionalSharesValue	0	usd
CY2024	us-gaap	Depreciation And Amortization DepreciationAndAmortization	685406	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	16856526	usd
CY2023	dynt	Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount PreferredStockDividendInCommonStockIssuedOrToBeIssuedAmount	0	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	1637	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	622450	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-2697719	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2024	dynt	Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount PreferredStockDividendInCommonStockIssuedOrToBeIssuedAmount	0	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	14160444	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-2697719	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4973368	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	726386	usd
CY2024	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-41389	usd
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	618300	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	1637	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	116725	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1715467	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4551373	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-296179	usd
CY2024	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-363544	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	455308	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2188578	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1610400	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	371114	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-186854	usd
CY2024	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	286522	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	327345	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-18542	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-148447	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-332707	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	701317	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	552870	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	534328	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	276742	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	552870	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	244421	usd
CY2024	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	252639	usd
CY2024	dynt	Preferred Stock Dividend In Common Stock Issued Or To Be Issued PreferredStockDividendInCommonStockIssuedOrToBeIssued	730873	usd
CY2023	dynt	Preferred Stock Dividend In Common Stock Issued Or To Be Issued PreferredStockDividendInCommonStockIssuedOrToBeIssued	690976	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2973474	usd
CY2024Q2	dynt	Cash And Cash Equivalents CashAndCashEquivalents	484000	usd
CY2023Q2	us-gaap	Common Unit Issuance Value CommonUnitIssuanceValue	690976	usd
CY2023Q2	dynt	Cash And Cash Equivalents CashAndCashEquivalents	399000	usd
CY2024Q2	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	50000	usd
CY2023Q2	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	154000	usd
CY2024	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	503566	shares
CY2022Q4	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	1-for-2
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	978201	shares
CY2024	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	1-for-5
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	one-for-five reverse stock split
CY2023	dynt	Cash And Cash Equivalents In Excess Of Federally Insured Limits CashAndCashEquivalentsInExcessOfFederallyInsuredLimits	246000	usd
CY2024	dynt	Percentage Of Collective Bargaining Agreement Scheduled To Expire PercentageOfCollectiveBargainingAgreementScheduledToExpire	0.46	pure
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	3596287	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3139131	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	4693634	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	315075	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	589683	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	66359	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2272295	usd
CY2023Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	495930	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	7403194	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	5593974	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1969413	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2448282	usd
CY2024	us-gaap	Depreciation Depreciation	680767	usd
CY2022Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	7705000	usd
CY2023	us-gaap	Indefinitelived Intangible Assets Acquired IndefinitelivedIntangibleAssetsAcquired	0	usd
CY2023	us-gaap	Indefinite Lived Intangible Assets Written Off Related To Sale Of Business Unit IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit	0	usd
CY2023Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	7705000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3464275	usd
CY2023	dynt	Finite Lived Intangible Assets Accumulated Amortization Additions FiniteLivedIntangibleAssetsAccumulatedAmortizationAdditions	622450	usd
CY2023	dynt	Finite Lived Intangible Assets Accumulated Amortization Disposal FiniteLivedIntangibleAssetsAccumulatedAmortizationDisposal	0	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4086725	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3618275	usd
CY2023Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	7705000	usd
CY2024	us-gaap	Indefinitelived Intangible Assets Acquired IndefinitelivedIntangibleAssetsAcquired	0	usd
CY2024	us-gaap	Indefinite Lived Intangible Assets Written Off Related To Sale Of Business Unit IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit	0	usd
CY2024Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	7705000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4086725	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4705025	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2999975	usd
CY2024	dynt	Finite Lived Intangible Assets Accumulated Amortization Disposal FiniteLivedIntangibleAssetsAccumulatedAmortizationDisposal	0	usd
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	618300	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	622450	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1915975	usd
CY2024Q2	us-gaap	Common Unit Issuance Value CommonUnitIssuanceValue	730873	usd
CY2024Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1365860	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	1633450	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1075690	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	302998	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	286522	usd
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1428870	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.092	pure
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1731868	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.085	pure
CY2024Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.048	pure
CY2023Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.056	pure
CY2024	us-gaap	Lease Cost LeaseCost	1391148	usd
CY2023	us-gaap	Lease Cost LeaseCost	1508728	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	120153	usd
CY2024Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	40164	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	43088	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	428200	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	591171	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	428080	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	0	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	424800	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	71032	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3321358	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	2184642	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	486942	usd
CY2024Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	452774	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2834416	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	1731868	usd
CY2024	us-gaap	Operating Lease Payments OperatingLeasePayments	745000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	449000	usd
CY2024	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	1339252	usd
CY2023	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	1078685	usd
CY2014Q3	dynt	Lease Term LeaseTerm	P15Y
CY2014Q3	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3800000	usd
CY2014Q3	us-gaap	Deferred Gain On Sale Of Property DeferredGainOnSaleOfProperty	2269255	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	28016	usd
CY2022Q3	dynt	Deferred Gain On Sale Of Property Recognized Period DeferredGainOnSaleOfPropertyRecognizedPeriod	P15Y
CY2024Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	29720	usd
CY2024Q2	dynt	Current Portion Of Deferred Gain CurrentPortionOfDeferredGain	150448	usd
CY2024Q2	dynt	Deferred Gain Net Of Noncurrent Portion DeferredGainNetOfNoncurrentPortion	626866	usd
CY2023Q2	dynt	Deferred Gain Net Of Noncurrent Portion DeferredGainNetOfNoncurrentPortion	777314	usd
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	566521	usd
CY2024	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	97884	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	156392	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1173848	usd
CY2024	dynt	Income Tax Reconciliation Change In Deferred Tax Assets Incentive Stock Options IncomeTaxReconciliationChangeInDeferredTaxAssetsIncentiveStockOptions	1657	usd
CY2023	dynt	Income Tax Reconciliation Change In Deferred Tax Assets Incentive Stock Options IncomeTaxReconciliationChangeInDeferredTaxAssetsIncentiveStockOptions	-22330	usd
CY2024	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-1582	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-4621	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	28642	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	43155	usd
CY2023Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	27883	usd
CY2024Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	574022	usd
CY2023Q2	us-gaap	Deferred Tax Assets Deferred Gain On Sale Leaseback Transaction DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction	224777	usd
CY2024Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5388117	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4719831	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6104053	usd
CY2020Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	200000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.8
CY2024	dynt	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P3Y9M
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	28000	shares
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	28000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2023	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	13.5
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.8
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	22250	shares
CY2023	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	4.65
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	8.26
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	1637	usd
CY2024	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	131336	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0	usd
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2024Q2	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable	670200	shares
CY2024	dynt	Description Of Formula For Paying Dividend DescriptionOfFormulaForPayingDividend	The Company generally pays the dividends on the preferred stock by issuing shares of our common stock. The formula for paying these dividends using common stock in lieu of cash can change the effective yield on the dividend to more or less than 8% depending on the market price of the common stock at the time of issuance.
CY2024	dynt	Dividend Rate DividendRate	0.08	pure
CY2024Q2	dynt	Warrants Issued And Outstanding WarrantsIssuedAndOutstanding	280001	shares
CY2024	dynt	Description Of Employee Benefit Plan DescriptionOfEmployeeBenefitPlan	For fiscal year 2024 and 2023, the Company made matching contributions of 50% of the first 6% of each employee's contribution up to a maximum of $3,000, with a four-year vesting schedule.
CY2023	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	241139	usd
CY2024	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	73112	usd
CY2024Q2	us-gaap	Cash Cash	483918	usd
CY2024Q2	dynt	Rebate Liability RebateLiability	263959	usd
CY2023Q2	us-gaap	Cash Cash	398797	usd
CY2023Q2	dynt	Rebate Liability RebateLiability	191459	usd
CY2024	dynt	Description Of Cash Flow DescriptionOfCashFlow	cash flows from consolidated operations, and current capital resources provide sufficient liquidity to fund operations through at least September 30, 2025.
CY2023	us-gaap	Interest Expense InterestExpense	118307	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5362	usd
CY2023	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2697719	usd
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-82406	usd
CY2024	dynt	Amortization Of Deferred Gain On Sale Leaseback AmortizationOfDeferredGainOnSaleLeaseback	-150448	usd
CY2023	dynt	Amortization Of Deferred Gain On Sale Leaseback AmortizationOfDeferredGainOnSaleLeaseback	-150448	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1835145	usd
CY2024	dei	Auditor Firm AuditorFirmId	270
CY2024	dei	Auditor Location AuditorLocation	Salt Lake City, Utah
CY2024Q2	us-gaap	Inventory Net InventoryNet	5593974	usd
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0000720875
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2024	dei	Security12b Title Security12bTitle	Common Stock
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Auditor Firm AuditorFirmId	270
CY2024	dei	Auditor Name AuditorName	Tanner LLC
CY2024	dei	Auditor Location AuditorLocation	Salt Lake City, Utah
CY2023Q2	us-gaap	Inventory Net InventoryNet	7403194	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2448282	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	189861	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2831417	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	201725	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	120677	usd
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3351000	shares
CY2023Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	7980788	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-28908169	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-424671	usd
CY2024	dei	Auditor Firm AuditorFirmId	270
CY2024	dei	Auditor Location AuditorLocation	Salt Lake City, Utah
CY2024Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	454390	usd
CY2023Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	39678	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1969413	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	4529703	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	877781	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	725727	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	891467	usd
CY2023Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	usd
CY2024	dei	Auditor Name AuditorName	Tanner LLC
CY2024	dei	Auditor Location AuditorLocation	Salt Lake City, Utah
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	530356	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	12418875	usd
CY2023Q2	us-gaap	Assets Assets	30062875	usd
CY2024Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2121667	usd
CY2023Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	302998	usd
CY2023Q2	dynt	Deferred Gain Net Of Noncurrent Portion DeferredGainNetOfNoncurrentPortion	777314	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	201725	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25940559	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2697719	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4973368	usd
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-82406	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-116821	usd
CY2023	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	690976	usd
CY2024	dynt	Amortization Of Deferred Gain On Sale Leaseback AmortizationOfDeferredGainOnSaleLeaseback	-150448	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2315207	usd
CY2024	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3428592	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5362	usd
CY2024	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	2121667	usd
CY2023	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5664344	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1835145	usd
CY2024Q2	us-gaap	Goodwill Goodwill	7116614	usd
CY2024Q2	us-gaap	Assets Assets	25940559	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2712142	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	566443	usd
CY2024Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2121667	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	286522	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1004808	usd
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1428870	usd
CY2024Q2	dynt	Current Portion Of Deferred Gain CurrentPortionOfDeferredGain	150448	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	189861	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	201725	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9908026	usd
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6666	usd
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3421606	shares
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3421606	shares
CY2024	us-gaap	Inventory Write Down InventoryWriteDown	93753	usd
CY2024	dynt	Amortization Of Deferred Gain On Sale Leaseback AmortizationOfDeferredGainOnSaleLeaseback	-150448	usd
CY2023	dynt	Amortization Of Deferred Gain On Sale Leaseback AmortizationOfDeferredGainOnSaleLeaseback	-150448	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-359496	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-243287	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5362	usd
CY2024	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	2121667	usd
CY2023	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1835145	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1829608	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1835145	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	189861	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	201725	usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	86119	usd
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3351000	shares
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-2697719	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4973368	usd
CY2024	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	730873	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.46
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-116821	usd
CY2024	dynt	Amortization Of Deferred Gain On Sale Leaseback AmortizationOfDeferredGainOnSaleLeaseback	-150448	usd
CY2023	dynt	Amortization Of Deferred Gain On Sale Leaseback AmortizationOfDeferredGainOnSaleLeaseback	-150448	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	243612	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	243287	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5362	usd
CY2024	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	2121667	usd
CY2023	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-121705	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2697719	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	131336	usd
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-82406	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-116821	usd
CY2024	dynt	Amortization Of Deferred Gain On Sale Leaseback AmortizationOfDeferredGainOnSaleLeaseback	-150448	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1811188	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	186854	usd
CY2024	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5362	usd
CY2024	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	2121667	usd
CY2023	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1835145	usd
CY2024	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2024	us-gaap	Nature Of Operations NatureOfOperations	<div> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><i><b>Description of Business</b></i></span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Dynatronics Corporation ("Company," or "Dynatronics") is a leading medical device company committed to providing high-quality products designed to accelerate optimal health. The Company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals.</span></span></p> </div>
CY2024	dynt	Cash And Cash Equivalents In Excess Of Federally Insured Limits CashAndCashEquivalentsInExcessOfFederallyInsuredLimits	160000	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><i><b>Use of Estimates</b></i></span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Management of the Company has made a number of estimates and assumptions relating to the reporting of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities in accordance with U.S. GAAP. Significant items subject to such estimates and assumptions include the impairment and useful lives of long-lived assets; receivable valuation allowances for credit losses, deferred income taxes, and obsolete inventories; accrued product warranty costs; and fair values of assets acquired and liabilities assumed in an acquisition. Actual results could differ from those estimates.</span></span></p> </div>
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><i><b>Concentration of Risk</b></i></span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">In the normal course of business, the Company provides unsecured credit to its customers. Most of the Company's customers are involved in the medical industry. The Company performs ongoing credit evaluations of its customers and maintains allowances for probable losses which, when realized, have been within the range of management's expectations. The Company maintains its cash in bank deposit accounts which at times may exceed federally insured limits.</span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">As of June 30, 2024 and 2023, the Company had approximately $160,000 and $246,000, respectively, in cash and cash equivalents in excess of federally insured limits. The Company has not experienced any losses in such accounts. Certain of the Company's employees are covered by a collective bargaining agreement. As of June 30, 2024, approximately 46% of the Company's employees were covered by a collective bargaining agreement scheduled to expire in 2025.</span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">For the year ended June 30, 2024, the Company had two customers that represented 29% and 11% of net accounts receivable.</span></span></p> </div>
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7209204	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	618300	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	571549	usd
CY2023	dynt	Other Receivables Contract Manufacturer OtherReceivablesContractManufacturer	443000	usd
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><i><b>Concentration of Risk</b></i></span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">In the normal course of business, the Company provides unsecured credit to its customers. Most of the Company's customers are involved in the medical industry. The Company performs ongoing credit evaluations of its customers and maintains allowances for probable losses which, when realized, have been within the range of management's expectations. The Company maintains its cash in bank deposit accounts which at times may exceed federally insured limits.</span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">As of June 30, 2024 and 2023, the Company had approximately $160,000 and $246,000, respectively, in cash and cash equivalents in excess of federally insured limits. The Company has not experienced any losses in such accounts. Certain of the Company's employees are covered by a collective bargaining agreement. As of June 30, 2024, approximately 46% of the Company's employees were covered by a collective bargaining agreement scheduled to expire in 2025.</span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">For the year ended June 30, 2024, the Company had two customers that represented 29% and 11% of net accounts receivable.</span></span></p> </div>
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><i><b>Concentration of Risk</b></i></span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">In the normal course of business, the Company provides unsecured credit to its customers. Most of the Company's customers are involved in the medical industry. The Company performs ongoing credit evaluations of its customers and maintains allowances for probable losses which, when realized, have been within the range of management's expectations. The Company maintains its cash in bank deposit accounts which at times may exceed federally insured limits.</span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">As of June 30, 2024 and 2023, the Company had approximately $160,000 and $246,000, respectively, in cash and cash equivalents in excess of federally insured limits. The Company has not experienced any losses in such accounts. Certain of the Company's employees are covered by a collective bargaining agreement. As of June 30, 2024, approximately 46% of the Company's employees were covered by a collective bargaining agreement scheduled to expire in 2025.</span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">For the year ended June 30, 2024, the Company had two customers that represented 29% and 11% of net accounts receivable.</span></span></p> </div>
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7408016	usd
CY2024	dynt	Operating Lease Weighted Average Remaining Lease Term OperatingLeaseWeightedAverageRemainingLeaseTerm	P3Y3M18D
CY2023	dynt	Operating Lease Weighted Average Remaining Lease Term OperatingLeaseWeightedAverageRemainingLeaseTerm	P4Y
CY2024	dynt	Finance Lease Weighted Average Remaining Lease Term FinanceLeaseWeightedAverageRemainingLeaseTerm	P4Y4M24D
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	618300	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	618300	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	571549	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	107826	usd
CY2024Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2121667	usd
CY2024	us-gaap	Line Of Credit Facility Collateral Fees Amount LineOfCreditFacilityCollateralFeesAmount	190030	usd
CY2023	us-gaap	Line Of Credit Facility Collateral Fees Amount LineOfCreditFacilityCollateralFeesAmount	0	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1829608	usd
CY2023	us-gaap	Depreciation Depreciation	421514	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	618300	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	618300	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	571549	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	107826	usd
CY2024Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2121667	usd
CY2023Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	usd
CY2024	us-gaap	Line Of Credit Facility Collateral Fees Amount LineOfCreditFacilityCollateralFeesAmount	190030	usd
CY2023	us-gaap	Line Of Credit Facility Collateral Fees Amount LineOfCreditFacilityCollateralFeesAmount	0	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2831417	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2554450	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3631780	usd
CY2023	dynt	Operating Lease Weighted Average Remaining Lease Term OperatingLeaseWeightedAverageRemainingLeaseTerm	P4Y
CY2024	dynt	Finance Lease Weighted Average Remaining Lease Term FinanceLeaseWeightedAverageRemainingLeaseTerm	P4Y4M24D
CY2023	dynt	Finance Lease Weighted Average Remaining Lease Term FinanceLeaseWeightedAverageRemainingLeaseTerm	P6Y1M6D
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5438603	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4760922	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	618300	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	618300	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	571549	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	107826	usd
CY2024Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2121667	usd
CY2023Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	usd
CY2024	us-gaap	Line Of Credit Facility Collateral Fees Amount LineOfCreditFacilityCollateralFeesAmount	190030	usd
CY2023	us-gaap	Line Of Credit Facility Collateral Fees Amount LineOfCreditFacilityCollateralFeesAmount	0	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1004808	usd
CY2024	dynt	Finite Lived Intangible Assets Accumulated Amortization Additions FiniteLivedIntangibleAssetsAccumulatedAmortizationAdditions	618300	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	618300	usd
CY2024Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2121667	usd
CY2023Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	usd
CY2024	us-gaap	Line Of Credit Facility Collateral Fees Amount LineOfCreditFacilityCollateralFeesAmount	190030	usd
CY2023	us-gaap	Line Of Credit Facility Collateral Fees Amount LineOfCreditFacilityCollateralFeesAmount	0	usd
CY2024	dynt	Operating Lease Weighted Average Remaining Lease Term OperatingLeaseWeightedAverageRemainingLeaseTerm	P3Y3M18D
CY2023	dynt	Operating Lease Weighted Average Remaining Lease Term OperatingLeaseWeightedAverageRemainingLeaseTerm	P4Y
CY2024	dynt	Finance Lease Weighted Average Remaining Lease Term FinanceLeaseWeightedAverageRemainingLeaseTerm	P4Y4M24D
CY2023	dynt	Finance Lease Weighted Average Remaining Lease Term FinanceLeaseWeightedAverageRemainingLeaseTerm	P6Y1M6D
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	420188	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	776063	usd
CY2024	dynt	Operating Leases Extension OperatingLeasesExtension	The Company has exercised the option to extend the term of the New Jersey facility operating lease by five years through March 31, 2028. For the Minnesota facility operating lease, the Company exercised an extension for six months through April 2024, and subsequently another extension through December 2025.
CY2024Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2121667	usd
CY2024	us-gaap	Line Of Credit Facility Collateral Fees Amount LineOfCreditFacilityCollateralFeesAmount	190030	usd
CY2023	us-gaap	Line Of Credit Facility Collateral Fees Amount LineOfCreditFacilityCollateralFeesAmount	0	usd
CY2023	dynt	Operating Lease Weighted Average Remaining Lease Term OperatingLeaseWeightedAverageRemainingLeaseTerm	P4Y
CY2024	dynt	Finance Lease Weighted Average Remaining Lease Term FinanceLeaseWeightedAverageRemainingLeaseTerm	P4Y4M24D
CY2023	dynt	Finance Lease Weighted Average Remaining Lease Term FinanceLeaseWeightedAverageRemainingLeaseTerm	P6Y1M6D
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	760268	usd
CY2024	dynt	Operating Lease Weighted Average Remaining Lease Term OperatingLeaseWeightedAverageRemainingLeaseTerm	P3Y3M18D
CY2023	dynt	Operating Lease Weighted Average Remaining Lease Term OperatingLeaseWeightedAverageRemainingLeaseTerm	P4Y
CY2024	dynt	Finance Lease Weighted Average Remaining Lease Term FinanceLeaseWeightedAverageRemainingLeaseTerm	P4Y4M24D
CY2023	dynt	Finance Lease Weighted Average Remaining Lease Term FinanceLeaseWeightedAverageRemainingLeaseTerm	P6Y1M6D
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2024	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	11543	usd
CY2024	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11543	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1193856	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2024	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2024	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	11543	usd
CY2024	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-11543	usd
CY2024	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	11543	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11543	usd
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-664480	usd
CY2024Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	35918	usd
CY2024Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	412342	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2024Q2	dynt	Deferred Gain DeferredGain	777314	usd
CY2024	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2024	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	11543	usd
CY2024	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-11543	usd
CY2024	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11543	usd
CY2024	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2024	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	11543	usd
CY2024	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-11543	usd
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	11543	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11543	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	145227	usd
CY2024Q2	dynt	Deferred Tax Assets Interest Expense Limitation DeferredTaxAssetsInterestExpenseLimitation	339509	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	85351	usd
CY2024Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	3448	usd
CY2024Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	35918	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023Q2	dynt	Deferred Gain DeferredGain	927762	usd
CY2024Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023Q2	dynt	Current Portion Of Deferred Gain CurrentPortionOfDeferredGain	150448	usd
CY2024	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2024	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	11543	usd
CY2024	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-11543	usd
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	11543	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11543	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1044407	usd
CY2024Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	35918	usd
CY2023Q2	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	4361	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023Q2	dynt	Deferred Tax Assets Interest Expense Limitation DeferredTaxAssetsInterestExpenseLimitation	233416	usd
CY2024Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	35918	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	85351	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	574022	usd
CY2024Q2	us-gaap	Deferred Tax Assets Deferred Gain On Sale Leaseback Transaction DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction	191436	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6884228	usd
CY2024Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2024Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	35918	usd
CY2024Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	108025	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2024	dynt	Equity Incentive Paln Description EquityIncentivePalnDescription	On December 3, 2018, the shareholders approved the 2018 equity incentive plan ("2018 Equity Plan"), setting aside 120,000 shares of common stock. On December 10, 2020, the shareholders approved a new 2020 equity incentive plan ("2020 Equity Plan"), setting aside 200,000 shares of common stock. Shares remaining available under the 2018 Equity Plan are eligible for use under the 2020 Equity Plan. Incentive and nonqualified stock options, restricted common stock, stock appreciation rights, and other share-based awards may be granted under the plans including performance-based awards.
CY2018Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	120000	shares
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	575745	shares
CY2024	dynt	Preferred Stock Redemption Price Percentage PreferredStockRedemptionPricePercentage	1.30	pure
CY2024	dynt	Equity Incentive Paln Description EquityIncentivePalnDescription	On December 3, 2018, the shareholders approved the 2018 equity incentive plan ("2018 Equity Plan"), setting aside 120,000 shares of common stock. On December 10, 2020, the shareholders approved a new 2020 equity incentive plan ("2020 Equity Plan"), setting aside 200,000 shares of common stock. Shares remaining available under the 2018 Equity Plan are eligible for use under the 2020 Equity Plan. Incentive and nonqualified stock options, restricted common stock, stock appreciation rights, and other share-based awards may be granted under the plans including performance-based awards.
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	28000	shares
CY2024	dynt	Preferred Stock Redemption Price Percentage PreferredStockRedemptionPricePercentage	1.30	pure
CY2024	us-gaap	Revenues Revenues	32533965	usd
CY2024	dynt	Equity Incentive Paln Description EquityIncentivePalnDescription	On December 3, 2018, the shareholders approved the 2018 equity incentive plan ("2018 Equity Plan"), setting aside 120,000 shares of common stock. On December 10, 2020, the shareholders approved a new 2020 equity incentive plan ("2020 Equity Plan"), setting aside 200,000 shares of common stock. Shares remaining available under the 2018 Equity Plan are eligible for use under the 2020 Equity Plan. Incentive and nonqualified stock options, restricted common stock, stock appreciation rights, and other share-based awards may be granted under the plans including performance-based awards.
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
CY2024	us-gaap	Dividends Preferred Stock DividendsPreferredStock	158906	usd
CY2024	dynt	Preferred Stock Redemption Price Percentage PreferredStockRedemptionPricePercentage	1.30	pure
CY2024	dynt	Equity Incentive Paln Description EquityIncentivePalnDescription	On December 3, 2018, the shareholders approved the 2018 equity incentive plan ("2018 Equity Plan"), setting aside 120,000 shares of common stock. On December 10, 2020, the shareholders approved a new 2020 equity incentive plan ("2020 Equity Plan"), setting aside 200,000 shares of common stock. Shares remaining available under the 2018 Equity Plan are eligible for use under the 2020 Equity Plan. Incentive and nonqualified stock options, restricted common stock, stock appreciation rights, and other share-based awards may be granted under the plans including performance-based awards.
CY2024	dynt	Preferred Stock Redemption Price Percentage PreferredStockRedemptionPricePercentage	1.30	pure
CY2024	dynt	Equity Incentive Paln Description EquityIncentivePalnDescription	On December 3, 2018, the shareholders approved the 2018 equity incentive plan ("2018 Equity Plan"), setting aside 120,000 shares of common stock. On December 10, 2020, the shareholders approved a new 2020 equity incentive plan ("2020 Equity Plan"), setting aside 200,000 shares of common stock. Shares remaining available under the 2018 Equity Plan are eligible for use under the 2020 Equity Plan. Incentive and nonqualified stock options, restricted common stock, stock appreciation rights, and other share-based awards may be granted under the plans including performance-based awards.
CY2024Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	194451	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.8
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	28000	shares
CY2024	dynt	Preferred Stock Redemption Price Percentage PreferredStockRedemptionPricePercentage	1.30	pure
CY2023	us-gaap	Revenues Revenues	40609372	usd

Files In Submission

Name	View Source	Status
0001062993-24-016944-index-headers.html	Edgar Link	pending
0001062993-24-016944-index.html	Edgar Link	pending
0001062993-24-016944.txt	Edgar Link	pending
0001062993-24-016944-xbrl.zip	Edgar Link	pending
dynt-20240630.xsd	Edgar Link	pending
exhibit10-14.htm	Edgar Link	pending
exhibit10-14xu001.jpg	Edgar Link	pending
exhibit10-14xu002.jpg	Edgar Link	pending
exhibit10-15.htm	Edgar Link	pending
exhibit10-15xu001.jpg	Edgar Link	pending
exhibit10-15xu002.jpg	Edgar Link	pending
exhibit10-15xu003.jpg	Edgar Link	pending
exhibit10-15xu004.jpg	Edgar Link	pending
exhibit10-15xu007.jpg	Edgar Link	pending
exhibit10-15xu008.jpg	Edgar Link	pending
exhibit21-1.htm	Edgar Link	pending
exhibit23-1.htm	Edgar Link	pending
exhibit31-1.htm	Edgar Link	pending
exhibit31-2.htm	Edgar Link	pending
exhibit32-1.htm	Edgar Link	pending
exhibit32-2.htm	Edgar Link	pending
exhibit4-4.htm	Edgar Link	pending
exhibit97.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
dynt-20240630_def.xml	Edgar Link	unprocessable
dynt-20240630_lab.xml	Edgar Link	unprocessable
form10k_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
dynt-20240630_cal.xml	Edgar Link	unprocessable
dynt-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DYNT
DYNATRONICS CORP Stock $dynt

2024 Q3 Form 10-K Financial Statement

#000106299324016944 Filed on September 24, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DYNT DYNATRONICS CORP Stock $dynt

2024 Q3 Form 10-K Financial Statement

#000106299324016944 Filed on September 24, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DYNT
DYNATRONICS CORP Stock $dynt